tiprankstipranks
Atea Pharmaceuticals (AVIR)
NASDAQ:AVIR
US Market
AVIR
Atea Pharmaceuticals
RESEARCH TOOLSreports

Atea Pharmaceuticals (AVIR) Financial Statements

Compare
245 Followers

Atea Pharmaceuticals Financial Overview

Atea Pharmaceuticals's market cap is currently $424.65M. The company's EPS TTM is $-0.57; its P/E ratio is -1.84; Atea Pharmaceuticals is scheduled to report earnings on March 5, 2026, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 351.37M
Gross Profit$ -416.00K$ -83.37M$ -70.09M$ -62.39M$ 184.16M
Operating Income$ -180.89M$ -192.95M$ -164.16M$ -130.65M$ 138.38M
EBITDA$ -180.89M$ -131.80M$ -119.59M$ -110.84M$ 138.41M
Net Income$ -158.35M$ -168.38M$ -135.96M$ -115.91M$ 121.19M
Balance Sheet
Cash & Short-Term Investments$ 301.83M$ 454.72M$ 578.11M$ 646.71M$ 764.38M
Total Assets$ 315.22M$ 464.67M$ 594.97M$ 666.71M$ 772.89M
Total Debt$ 843.00K$ 1.64M$ 2.40M$ 3.12M$ 197.00K
Net Debt$ -94.87M$ -63.05M$ -141.42M$ -643.59M$ -764.18M
Total Liabilities$ 39.78M$ 25.80M$ 39.78M$ 26.14M$ 62.81M
Stockholders' Equity$ 275.43M$ 438.87M$ 555.19M$ 640.57M$ 710.08M
Cash Flow
Free Cash Flow$ -132.03M$ -135.50M$ -85.39M$ -122.92M$ -87.01M
Operating Cash Flow$ -132.03M$ -135.50M$ -85.39M$ -120.98M$ -87.00M
Investing Cash Flow$ 188.79M$ 56.10M$ 40.30M$ -455.41M$ -4.00K
Financing Cash Flow$ -25.75M$ 267.00K$ 257.00K$ 370.00K$ 1.47M
Currency in USD

Atea Pharmaceuticals Earnings and Revenue History

Income Statement >

Atea Pharmaceuticals Debt to Assets

Balance Sheet >

Atea Pharmaceuticals Cash Flow

Cash Flow >

Atea Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >